Clinical Trial Update: A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA [Phase 3]

View source ↗

Summary

Phase 3 prospective validation study of albumin kinetics using tracer 123 I-HSA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Individuals
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Ake Norberg | Conditions: Healthy, SIRS | Phase 3 | Status: COMPLETED